Nicotinic Receptor Template-guided Drug Design

烟碱受体模板指导的药物设计

基本信息

项目摘要

DESCRIPTION (provided by applicant): The proposed study has grown from a collaboration of the Sharpless & Taylor laboratories to employ novel "click chemistry" to develop selective ligands for nicotinic acetylcholine receptor using the acetylcholine binding protein as the reaction vessel. The precursors are anchored to two sites on the receptor and contain extended azide and acetylene moieties that react by cycloaddition to form a triazole. The precursor ligands have modest affinity for the protein and react extremely slowly in solution. On the protein surface, the apposition of the reactant groups and the amphiphilic environment of the protein forces a rapid reaction leading to formation of high affinity complex. Synthesis employs combinatorial reactants, and a single or predominant product is formed that is characterized by DIOS mass spectrometry. Interestingly, this "freezeframe" procedure catches the complex in unanticipated conformations such that the high affinity regioisomer forms from a low abundance conformation. Initially acetylcholine binding proteins from Lymnaea and Aplysia are employed as templates to form selective nicotinic agents. By mutagenesis the template is modified to incorporate binding determinants of the a7 receptor and then the heterologous receptor subtypes found in the brain. Since this is effectively a "freeze-frame" reaction, conformational flexibility of the binding templates will be analyzed by decay of fluorescence anisotropy in separate studies. Complexes also offer the potential for X-ray crystallographic studies. Partal agonists and antagonists will be generated from combinatorial libraries using nicotine, epibatidine or other heterocycles or bicyclic rings as the active center and peripheral site anchoring loci. Cycloaddition products will be examined for affinity and specificity for the respective binding templates. Their selectivities will then be examined on nicotinic receptors formed from transfected receptor subunit combinations. The final stages of investigation will include studies in rodents to determine efficacy and toxicity.
描述(由申请人提供):拟议的研究由Sharpless和Taylor实验室合作发展而来,采用新颖的“点击化学”,以乙酰胆碱结合蛋白为反应容器,开发烟碱乙酰胆碱受体的选择性配体。前体固定在受体上的两个位点上,含有扩展的叠氮化物和乙炔基团,通过环加成反应形成三唑。前体配体对蛋白质有适度的亲和力,在溶液中反应极慢。在蛋白质表面,反应物基团的相对位置和蛋白质的两亲性环境迫使快速反应,形成高亲和复合物。合成采用组合反应物,形成单一的或主要的产物,用DIOS质谱法进行表征。有趣的是,这种“定格”程序捕获了意想不到的构象,例如高亲和区域异构体从低丰度构象形成。最初,从海藓和海藓中提取的乙酰胆碱结合蛋白被用作模板来形成选择性的尼古丁剂。通过诱变,模板被修改为结合a7受体的结合决定因子,然后是在大脑中发现的异源受体亚型。由于这实际上是一个“定格”反应,结合模板的构象灵活性将在单独的研究中通过荧光各向异性的衰减来分析。配合物也为x射线晶体学研究提供了潜力。部分激动剂和拮抗剂将利用尼古丁、依比替丁或其他杂环或双环作为活性中心和外周位点锚定位点的组合文库生成。将检查环加成产物对各自结合模板的亲和力和特异性。它们的选择性将在由转染的受体亚基组合形成的烟碱受体上进行检验。调查的最后阶段将包括对啮齿动物的研究,以确定其功效和毒性。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.
主要的免疫原性结构促进了依赖构象肌无力自身抗体,烟碱乙酰胆碱受体构象成熟和激动剂敏感性的结合。
Characterizing ligand-gated ion channel receptors with genetically encoded Ca2++ sensors.
  • DOI:
    10.1371/journal.pone.0016519
  • 发表时间:
    2011-01-28
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Yamauchi JG;Nemecz Á;Nguyen QT;Muller A;Schroeder LF;Talley TT;Lindstrom J;Kleinfeld D;Taylor P
  • 通讯作者:
    Taylor P
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PALMER William TAYLOR其他文献

PALMER William TAYLOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PALMER William TAYLOR', 18)}}的其他基金

MODELING THE STRUCTURE & DYNAMICS OF ACH ESTERASE CLUSTERS
结构建模
  • 批准号:
    8169346
  • 财政年份:
    2010
  • 资助金额:
    $ 49.34万
  • 项目类别:
MODELING THE STRUCTURE & DYNAMICS OF ACH ESTERASE CLUSTERS
结构建模
  • 批准号:
    7955236
  • 财政年份:
    2009
  • 资助金额:
    $ 49.34万
  • 项目类别:
MODELING THE STRUCTURE & DYNAMICS OF ACH ESTERASE CLUSTERS
结构建模
  • 批准号:
    7722341
  • 财政年份:
    2008
  • 资助金额:
    $ 49.34万
  • 项目类别:
NEUROLIGIN AND AUTISM
神经连接蛋白和自闭症
  • 批准号:
    7722403
  • 财政年份:
    2008
  • 资助金额:
    $ 49.34万
  • 项目类别:
Central nicotinic receptors in hypertension
高血压中枢烟碱受体
  • 批准号:
    7393843
  • 财政年份:
    2007
  • 资助金额:
    $ 49.34万
  • 项目类别:
NEUROLIGIN AND AUTISM
神经连接蛋白和自闭症
  • 批准号:
    7601030
  • 财政年份:
    2007
  • 资助金额:
    $ 49.34万
  • 项目类别:
MODELING THE STRUCTURE & DYNAMICS OF ACH ESTERASE CLUSTERS
结构建模
  • 批准号:
    7601688
  • 财政年份:
    2007
  • 资助金额:
    $ 49.34万
  • 项目类别:
ANALYSIS OF ACETYLCHOLINE BINDING PROTEIN AND ACETYLCHOLINE ESTERASE
乙酰胆碱结合蛋白和乙酰胆碱酯酶的分析
  • 批准号:
    7601095
  • 财政年份:
    2007
  • 资助金额:
    $ 49.34万
  • 项目类别:
ACETYLCHOLINE BINDING PROTEIN & ACETYLCHOLINE ESTERASE
乙酰胆碱结合蛋白
  • 批准号:
    7358062
  • 财政年份:
    2006
  • 资助金额:
    $ 49.34万
  • 项目类别:
Oxime-Assisted Catalysis of Organophosphates and Reactivation of AChE
有机磷酸酯的肟辅助催化和乙酰胆碱酯酶的再活化
  • 批准号:
    7471380
  • 财政年份:
    2006
  • 资助金额:
    $ 49.34万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 49.34万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 49.34万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 49.34万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 49.34万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 49.34万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 49.34万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 49.34万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 49.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了